Globus Medical Free Cash Flow 2010-2024 | GMED
Globus Medical annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Globus Medical free cash flow for the quarter ending December 31, 2024 was 405.21, a year-over-year.
- Globus Medical free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.
- Globus Medical annual free cash flow for 2024 was $0.405B, a 145.25% increase from 2023.
- Globus Medical annual free cash flow for 2023 was $0.165B, a 58.23% increase from 2022.
- Globus Medical annual free cash flow for 2022 was $0.104B, a 52.4% decline from 2021.
| Globus Medical Annual Free Cash Flow |
| 2024 |
405.21 |
| 2023 |
165.23 |
| 2022 |
104.42 |
| 2021 |
219.38 |
| 2020 |
135.14 |
| 2019 |
101.23 |
| 2018 |
126.95 |
| 2017 |
107.76 |
| 2016 |
106.91 |
| 2015 |
73.25 |
| 2014 |
54.42 |
| 2013 |
69.79 |
| 2012 |
51.84 |
| 2011 |
53.92 |
| 2010 |
58.99 |
| 2009 |
6.12 |
| Globus Medical Quarterly Free Cash Flow |
| 2024-12-31 |
405.21 |
| 2024-09-30 |
211.98 |
| 2024-06-30 |
50.28 |
| 2024-03-31 |
23.82 |
| 2023-12-31 |
165.23 |
| 2023-09-30 |
83.43 |
| 2023-06-30 |
54.48 |
| 2023-03-31 |
37.32 |
| 2022-12-31 |
104.42 |
| 2022-09-30 |
58.79 |
| 2022-06-30 |
37.85 |
| 2022-03-31 |
24.72 |
| 2021-12-31 |
219.38 |
| 2021-09-30 |
160.17 |
| 2021-06-30 |
100.70 |
| 2021-03-31 |
49.90 |
| 2020-12-31 |
135.14 |
| 2020-09-30 |
69.01 |
| 2020-06-30 |
33.09 |
| 2020-03-31 |
19.98 |
| 2019-12-31 |
101.23 |
| 2019-09-30 |
62.71 |
| 2019-06-30 |
18.91 |
| 2019-03-31 |
11.05 |
| 2018-12-31 |
126.95 |
| 2018-09-30 |
98.81 |
| 2018-06-30 |
61.40 |
| 2018-03-31 |
39.92 |
| 2017-12-31 |
107.76 |
| 2017-09-30 |
76.34 |
| 2017-06-30 |
54.37 |
| 2017-03-31 |
41.92 |
| 2016-12-31 |
106.91 |
| 2016-09-30 |
94.78 |
| 2016-06-30 |
58.69 |
| 2016-03-31 |
46.19 |
| 2015-12-31 |
73.25 |
| 2015-09-30 |
41.27 |
| 2015-06-30 |
22.71 |
| 2015-03-31 |
27.44 |
| 2014-12-31 |
54.42 |
| 2014-09-30 |
61.57 |
| 2014-06-30 |
29.35 |
| 2014-03-31 |
23.07 |
| 2013-12-31 |
69.79 |
| 2013-09-30 |
42.34 |
| 2013-06-30 |
14.30 |
| 2013-03-31 |
11.50 |
| 2012-12-31 |
51.84 |
| 2012-09-30 |
34.75 |
| 2012-06-30 |
23.03 |
| 2012-03-31 |
16.54 |
| 2011-12-31 |
53.93 |
| 2011-09-30 |
38.06 |
| 2011-06-30 |
18.38 |
| 2011-03-31 |
16.61 |
| 2010-12-31 |
|
| 2009-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$9.891B |
$2.519B |
|
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
|
